Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 81 matches for

Participant meetings

ORION-4 Participant newsletter Issue 02, 2025

ORION-4 is a research study that aims to find out if a new cholesterol lowering injection (inclisiran) safely reduces the risk of heart attacks and strokes in people who have already had one of these conditions, or who have had an operation or procedure to unblock their arteries.

ORION-4 newsletter, spring 2024

Over 7 ½ million people in the UK live with heart and circulatory diseases (known as cardiovascular disease). ORION-4 is a clinical trial to find out if inclisiran, a new treatment to lower bad cholesterol, can help to protect them. Your contribution to this research is very important - a big thank you for your support. This is an update on the trial progress that was sent to participants by mail in spring 2024.

Privacy notice for trial staff and investigators

For patients: overview

Eligibility criteria

Data protection information for patients in Scotland who might be invited to take part in ORION-4

Test Homepage

test redirection

Where is the study registered?

Data protection information for patients in England & Wales who might be invited to take part in ORION-4

Privacy Notice for ORION-4 UK participants

Organisation and funding

Data Protection

Our Team

About us

Homepage

Cookies

Accessibility

Accessibility statement for the Orion 4 Trial website (www.orion4trial.org)